Heal like a mutant. BPC-157 + TB-500 — the most talked-about, most tried-and-tested repair combination in the entire research community.
Before you read on: this page reflects our own take on how these two compounds are typically used together, built from our own research and what's widely discussed in the research community — not a clinical trial designed around this exact combination, and not medical advice. Please talk to a qualified healthcare professional before starting any protocol. Everything below is offered for research and informational purposes only.
If you've spent any time at all in peptide research circles, you've heard of this combination. BPC-157 and TB-500 together is probably the single most tried, tested and discussed protocol in the entire space — more people have run this exact pairing, compared notes on it, and built on each other's experience with it than almost any other stack out there.
That matters. It means you're not the first person figuring out how these two work together — there's a genuinely large body of collective research experience behind this specific combination, on top of each compound's own individual research base. That's exactly why it's the first stack we built a dedicated page for.
BPC-157 is studied for angiogenesis (new blood vessel formation via VEGFR2), cell migration, and anti-inflammatory activity — the mechanisms behind its reputation for tendon, ligament, muscle and gut repair. It's the compound most people reach for first when dealing with a specific injury or a gut health issue they want to address directly.
BPC-157 clears quickly — most research protocols use once or twice daily dosing to maintain meaningful exposure. This is the compound in the stack that needs the most frequent attention.
TB-500 works through a different mechanism entirely — actin regulation and cell migration at a systemic level, rather than localised to one injury site. It's studied for broader recovery, flexibility, and inflammation control across the whole body, which is what makes it a genuine complement to BPC-157's more targeted repair activity rather than a duplicate of it.
TB-500 behaves completely differently to BPC-157 here — most research protocols use just twice-weekly dosing, not daily. This mismatch is the single most important thing to understand before you decide how to buy this stack.
We sell the Wolverine Bundle, and plenty of people buy it — convenience is a real thing, and not everyone wants to manage two separate reconstitution and dosing schedules. No judgment there.
But if you're asking us directly what the science actually supports, here it is: BPC-157 and TB-500 don't share the same half-life. BPC-157 clears fast enough that most protocols dose it once or twice a day. TB-500 sticks around long enough that it's typically dosed just twice a week. A bundle sold as one product tends to nudge people toward dosing both on the same schedule — which means either the BPC-157 is underdosed relative to what its half-life actually calls for, or the TB-500 is dosed more often than the research suggests is necessary.
If you're genuinely serious about getting the most out of this stack — not just trying it because everyone talks about it, but optimising it — our honest recommendation is to buy BPC-157 and TB-500 separately, and run each on its own schedule: BPC-157 once or twice daily, TB-500 twice weekly. That's the version of this stack that actually respects what each compound's own research says about it.
Want convenience and you're comfortable with a shared schedule? The bundle is a reasonable choice. Want to optimise for results based on the actual pharmacokinetics of each compound? Buy them separately and dose them on their own schedules. Both are legitimate — just be clear on which one you're choosing and why.
| Compound | Mechanism | Typical Dosing |
|---|---|---|
| BPC-157 | Angiogenesis (VEGFR2), local cell migration, anti-inflammatory | Once–twice daily |
| TB-500 | Actin regulation, systemic cell migration, broad recovery | Twice weekly |
This is our own read on how these two are most commonly used together, based on our research and what's widely discussed in the community — not a clinical protocol, not doctor-reviewed. Always do your own research and talk to a professional before starting anything.